174 related articles for article (PubMed ID: 36792932)
1. Reactive Oxygen Species as Mediators of Disease Progression and Therapeutic Response in Colorectal Cancer.
Lyons NJ; Giri R; Begun J; Clark D; Proud D; He Y; Hooper JD; Kryza T
Antioxid Redox Signal; 2023 Jul; 39(1-3):186-205. PubMed ID: 36792932
[No Abstract] [Full Text] [Related]
2. Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model.
Suehiro S; Ohnishi T; Yamashita D; Kohno S; Inoue A; Nishikawa M; Ohue S; Tanaka J; Kunieda T
J Neurosurg; 2018 Dec; 129(6):1416-1428. PubMed ID: 29350596
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
Kwon S; Ko H; You DG; Kataoka K; Park JH
Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
[TBL] [Abstract][Full Text] [Related]
4. Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies.
Stummer W; Müther M; Spille D
Acta Neurochir (Wien); 2024 Apr; 166(1):163. PubMed ID: 38563988
[TBL] [Abstract][Full Text] [Related]
5. Reactive Oxygen Species and Ferroptosis at the Nexus of Inflammation and Colon Cancer.
Huang W; Aabed N; Shah YM
Antioxid Redox Signal; 2023 Sep; 39(7-9):551-568. PubMed ID: 36792928
[No Abstract] [Full Text] [Related]
6. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway.
Huang YF; Zhu DJ; Chen XW; Chen QK; Luo ZT; Liu CC; Wang GX; Zhang WJ; Liao NZ
Oncotarget; 2017 Jun; 8(25):40264-40275. PubMed ID: 28402965
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species and colorectal cancer.
Lin S; Li Y; Zamyatnin AA; Werner J; Bazhin AV
J Cell Physiol; 2018 Jul; 233(7):5119-5132. PubMed ID: 29215746
[TBL] [Abstract][Full Text] [Related]
8. An in vitro study on sonodynamic treatment of human colon cancer cells using sinoporphyrin sodium as sonosensitizer.
Shen Y; Ou J; Chen X; Zeng X; Huang L; Pi Z; Hu Y; Chen S; Chen T
Biomed Eng Online; 2020 Jun; 19(1):52. PubMed ID: 32552718
[TBL] [Abstract][Full Text] [Related]
9. Treating cancer with sonodynamic therapy: a review.
Costley D; Mc Ewan C; Fowley C; McHale AP; Atchison J; Nomikou N; Callan JF
Int J Hyperthermia; 2015 Mar; 31(2):107-17. PubMed ID: 25582025
[TBL] [Abstract][Full Text] [Related]
10. Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer.
Wan G; Chen X; Wang H; Hou S; Wang Q; Cheng Y; Chen Q; Lv Y; Chen H; Zhang Q
J Nanobiotechnology; 2021 Oct; 19(1):347. PubMed ID: 34715867
[TBL] [Abstract][Full Text] [Related]
11. A General Method to Establish the Relative Efficiency of Different Sonosensitizers to Generate ROS for SDT.
Grosso V; Senz A; Soltermann AT
Methods Mol Biol; 2021; 2202():189-197. PubMed ID: 32857356
[TBL] [Abstract][Full Text] [Related]
12. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
[TBL] [Abstract][Full Text] [Related]
13. Low-dose X-ray radiodynamic therapy solely based on gold nanoclusters for efficient treatment of deep hypoxic solid tumors combined with enhanced antitumor immune response.
Zhu S; Yan F; Yang L; Li B; Xue R; Yu W; Wang Y; Huang L; Wang L; Han R; Jiang Y
Theranostics; 2023; 13(3):1042-1058. PubMed ID: 36793856
[No Abstract] [Full Text] [Related]
14. Recent progress in the augmentation of reactive species with nanoplatforms for cancer therapy.
Wu M; Ding Y; Li L
Nanoscale; 2019 Nov; 11(42):19658-19683. PubMed ID: 31612164
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species in colorectal cancer: The therapeutic impact and its potential roles in tumor progression via perturbation of cellular and physiological dysregulated pathways.
Moradi-Marjaneh R; Hassanian SM; Mehramiz M; Rezayi M; Ferns GA; Khazaei M; Avan A
J Cell Physiol; 2019 Jul; 234(7):10072-10079. PubMed ID: 30515827
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-Targeted Nanomedicine for Enhanced Efficacy of Cancer Therapy.
Gao Y; Tong H; Li J; Li J; Huang D; Shi J; Xia B
Front Bioeng Biotechnol; 2021; 9():720508. PubMed ID: 34490227
[TBL] [Abstract][Full Text] [Related]
17. Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy.
Li Y; Yang J; Sun X
Front Chem; 2021; 9():650587. PubMed ID: 33968899
[TBL] [Abstract][Full Text] [Related]
18. Sinoporphyrin sodium, a novel sensitizer, triggers mitochondrial-dependent apoptosis in ECA-109 cells via production of reactive oxygen species.
Wang H; Wang X; Zhang S; Wang P; Zhang K; Liu Q
Int J Nanomedicine; 2014; 9():3077-90. PubMed ID: 25028547
[TBL] [Abstract][Full Text] [Related]
19. Role of Bcl-2 Family Proteins in Photodynamic Therapy Mediated Cell Survival and Regulation.
Aniogo EC; George BPA; Abrahamse H
Molecules; 2020 Nov; 25(22):. PubMed ID: 33203053
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
